Cargando…
Efficient Chemical Synthesis of (Epi)catechin Glucuronides: Brain-Targeted Metabolites for Treatment of Alzheimer’s Disease and Other Neurological Disorders
[Image: see text] Grape seed extract (GSE) is rich in flavonoids and has been recognized to possess human health benefits. Our group and others have demonstrated that GSE is able to attenuate the development of Alzheimer’s disease (AD). Moreover, our results have disclosed that the anti-Alzheimer’s...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689943/ https://www.ncbi.nlm.nih.gov/pubmed/33251444 http://dx.doi.org/10.1021/acsomega.0c04512 |
_version_ | 1783613966632615936 |
---|---|
author | Docampo-Palacios, Maite L. Alvarez-Hernández, Anislay de Fátima, Ângelo Lião, Luciano Morais Pasinetti, Giulio M. Dixon, Richard A. |
author_facet | Docampo-Palacios, Maite L. Alvarez-Hernández, Anislay de Fátima, Ângelo Lião, Luciano Morais Pasinetti, Giulio M. Dixon, Richard A. |
author_sort | Docampo-Palacios, Maite L. |
collection | PubMed |
description | [Image: see text] Grape seed extract (GSE) is rich in flavonoids and has been recognized to possess human health benefits. Our group and others have demonstrated that GSE is able to attenuate the development of Alzheimer’s disease (AD). Moreover, our results have disclosed that the anti-Alzheimer’s benefits are not directly/solely related to the dietary flavonoids themselves, but rather to their metabolites, particularly to the glucuronidated ones. To facilitate the understanding of regioisomer/stereoisomer-specific biological effects of (epi)catechin glucuronides, we here describe a concise chemical synthesis of authentic standards of catechin and epicatechin metabolites 3–12. The synthesis of glucuronides 9 and 12 is described here for the first time. The key reactions employed in the synthesis of the novel glucuronides 9 and 12 include the regioselective methylation of the 4′-hydroxyl group of (epi)catechin (≤1.0/99.0%; 3′-OMe/4′-OMe) and the regioselective deprotection of the tert-butyldimethylsilyl (TBS) group at position 5 (yielding up to 79%) over the others (3, 7 and 3′ or 4′). |
format | Online Article Text |
id | pubmed-7689943 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-76899432020-11-27 Efficient Chemical Synthesis of (Epi)catechin Glucuronides: Brain-Targeted Metabolites for Treatment of Alzheimer’s Disease and Other Neurological Disorders Docampo-Palacios, Maite L. Alvarez-Hernández, Anislay de Fátima, Ângelo Lião, Luciano Morais Pasinetti, Giulio M. Dixon, Richard A. ACS Omega [Image: see text] Grape seed extract (GSE) is rich in flavonoids and has been recognized to possess human health benefits. Our group and others have demonstrated that GSE is able to attenuate the development of Alzheimer’s disease (AD). Moreover, our results have disclosed that the anti-Alzheimer’s benefits are not directly/solely related to the dietary flavonoids themselves, but rather to their metabolites, particularly to the glucuronidated ones. To facilitate the understanding of regioisomer/stereoisomer-specific biological effects of (epi)catechin glucuronides, we here describe a concise chemical synthesis of authentic standards of catechin and epicatechin metabolites 3–12. The synthesis of glucuronides 9 and 12 is described here for the first time. The key reactions employed in the synthesis of the novel glucuronides 9 and 12 include the regioselective methylation of the 4′-hydroxyl group of (epi)catechin (≤1.0/99.0%; 3′-OMe/4′-OMe) and the regioselective deprotection of the tert-butyldimethylsilyl (TBS) group at position 5 (yielding up to 79%) over the others (3, 7 and 3′ or 4′). American Chemical Society 2020-11-12 /pmc/articles/PMC7689943/ /pubmed/33251444 http://dx.doi.org/10.1021/acsomega.0c04512 Text en © 2020 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes. |
spellingShingle | Docampo-Palacios, Maite L. Alvarez-Hernández, Anislay de Fátima, Ângelo Lião, Luciano Morais Pasinetti, Giulio M. Dixon, Richard A. Efficient Chemical Synthesis of (Epi)catechin Glucuronides: Brain-Targeted Metabolites for Treatment of Alzheimer’s Disease and Other Neurological Disorders |
title | Efficient Chemical Synthesis of (Epi)catechin Glucuronides:
Brain-Targeted Metabolites for Treatment of Alzheimer’s Disease
and Other Neurological Disorders |
title_full | Efficient Chemical Synthesis of (Epi)catechin Glucuronides:
Brain-Targeted Metabolites for Treatment of Alzheimer’s Disease
and Other Neurological Disorders |
title_fullStr | Efficient Chemical Synthesis of (Epi)catechin Glucuronides:
Brain-Targeted Metabolites for Treatment of Alzheimer’s Disease
and Other Neurological Disorders |
title_full_unstemmed | Efficient Chemical Synthesis of (Epi)catechin Glucuronides:
Brain-Targeted Metabolites for Treatment of Alzheimer’s Disease
and Other Neurological Disorders |
title_short | Efficient Chemical Synthesis of (Epi)catechin Glucuronides:
Brain-Targeted Metabolites for Treatment of Alzheimer’s Disease
and Other Neurological Disorders |
title_sort | efficient chemical synthesis of (epi)catechin glucuronides:
brain-targeted metabolites for treatment of alzheimer’s disease
and other neurological disorders |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689943/ https://www.ncbi.nlm.nih.gov/pubmed/33251444 http://dx.doi.org/10.1021/acsomega.0c04512 |
work_keys_str_mv | AT docampopalaciosmaitel efficientchemicalsynthesisofepicatechinglucuronidesbraintargetedmetabolitesfortreatmentofalzheimersdiseaseandotherneurologicaldisorders AT alvarezhernandezanislay efficientchemicalsynthesisofepicatechinglucuronidesbraintargetedmetabolitesfortreatmentofalzheimersdiseaseandotherneurologicaldisorders AT defatimaangelo efficientchemicalsynthesisofepicatechinglucuronidesbraintargetedmetabolitesfortreatmentofalzheimersdiseaseandotherneurologicaldisorders AT liaolucianomorais efficientchemicalsynthesisofepicatechinglucuronidesbraintargetedmetabolitesfortreatmentofalzheimersdiseaseandotherneurologicaldisorders AT pasinettigiuliom efficientchemicalsynthesisofepicatechinglucuronidesbraintargetedmetabolitesfortreatmentofalzheimersdiseaseandotherneurologicaldisorders AT dixonricharda efficientchemicalsynthesisofepicatechinglucuronidesbraintargetedmetabolitesfortreatmentofalzheimersdiseaseandotherneurologicaldisorders |